What are the best treatments for Rett Syndrome?

There is currently no cure for Rett syndrome, so treatment focuses on a multidisciplinary approach to manage symptoms, improve quality of life, and maximize functional independence. Current clinical management involves a combination of specialized therapies, supportive care, and the use of targeted medications like trofinetide to address specific neurological manifestations.

What are the current medical and pharmacological treatments for Rett syndrome?

Management of Rett syndrome is highly individualized because the clinical presentation varies significantly based on the specific genetic mutation and the stage of the disease. In 2023, the FDA approved trofinetide (Daybue), the first medication specifically indicated for the treatment of Rett syndrome in adults and pediatric patients two years of age and older. This medication aims to address core symptoms by mimicking the function of IGF-1, a protein essential for brain development. Beyond this, physicians typically prescribe medications to manage secondary symptoms, such as antiepileptic drugs for seizures, melatonin for sleep disturbances, and medications to manage gastrointestinal issues like constipation or acid reflux.

What non-pharmacological therapies are essential for managing Rett syndrome?

Non-pharmacological interventions are the cornerstone of care for individuals living with Rett syndrome. These therapies are designed to maintain physical mobility, facilitate communication, and support daily living activities. A comprehensive therapeutic plan often includes:

• Physical Therapy: Focuses on maintaining range of motion, improving posture, and preventing scoliosis, which affects approximately 80% of patients with Rett syndrome.


• Occupational Therapy: Assists in developing motor skills and adapting the environment to support sensory processing and daily independence.


• Speech and Language Therapy: Often incorporates augmentative and alternative communication (AAC) devices, such as eye-gaze technology, to help patients express needs despite the loss of verbal speech.


• Hydrotherapy: Often recommended to provide a weightless environment that helps reduce muscle tone and improve comfort.

Which specialists should be on a multidisciplinary care team?

Because Rett syndrome is a complex neurodevelopmental disorder, care requires coordination among various medical disciplines. A robust care team should include a neurologist (preferably with expertise in neurodevelopmental disorders), a clinical geneticist, a gastroenterologist, a physiatrist, and an orthopedist to monitor for spinal deformities. Speech, physical, and occupational therapists are also vital members of this team. At DiseaseMaps.org, 416 people with Rett syndrome have joined our community, and many report that consistent coordination between these specialists is the single most important factor in long-term symptom management.

What is the outlook for emerging treatments in clinical trials?

Research into Rett syndrome is rapidly evolving. Current clinical trials are investigating gene replacement therapies and small-molecule drugs that aim to restore MECP2 function or modulate downstream signaling pathways. While some therapies show promise in preclinical models, it is essential to consult with a specialist physician to determine if a clinical trial is an appropriate option for a specific patient, as eligibility criteria are strict and safety profiles are still being established.

Next steps

• Consult with a neurologist specializing in neurodevelopmental disorders to develop a personalized care plan.


• Connect with the community at DiseaseMaps.org to share experiences with other families living with Rett syndrome.


• Regularly screen for scoliosis and cardiac abnormalities, as these are common clinical concerns in this population.


• Explore resources from the International Rett Syndrome Foundation for the latest updates on clinical research and caregiver support.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Rett Syndrome Overview.


• Orphanet: Rare Disease Database (ORPHA:771).


• International Rett Syndrome Foundation (IRSF): Clinical Management Guidelines.


• OMIM (Online Mendelian Inheritance in Man): Entry #312750 (Rett Syndrome).